Skip to ContentSkip to Navigation
breed in kennis  -  sterk in techniek
Over ons Praktische zaken Waar vindt u ons dr. M.A. Heuvelmans

Publicaties

A Game-Changing 20 Years: Progress and Future Directions in Lung Cancer Screening

AI performance for nodule volume doubling time in the follow-up of the UKLS lung cancer screening study compared to expert consensus and histological validation

Artificial intelligence as an independent reader of risk-dominant lung nodules: influence of CT reconstruction parameters

Association of CT-assessed sarcopenia and the development of immune-related adverse events and overall survival: a multistate survival analysis

CT-based body composition and its change through time in relation to outcomes in participants screened for lung cancer

Improving Lung Cancer Screening Selection: A Comparative Analysis of Risk Models and Traditional Criteria in a Western European General Population

Incidence and lung cancer probability of new nodules in the UK lung screening trial

Negligible impact of perifissural nodules in an AI-first reader workflow from UK lung screening trial

Repeatability of automated body composition measurement on low dose chest CT in male subjects

Sex-based differences in effectiveness of immune checkpoint inhibitors in the treatment of advanced non-small-cell lung cancer: systematic review and meta-analysis

Sustainable Development Goals

SDG 3 – Goede gezondheid en welzijnSDG 10 – Minder ongelijkheidSDG 16 – Vrede, rechtvaardigheid en sterke instellingen

Meer informatie over de Sustainable Development Goals.